ICICI Bank Ltd vs Nexus Surgical and Medicare Ltd

A side-by-side comparison of ICICI Bank Ltd (ICICIBANK) and Nexus Surgical and Medicare Ltd (NEXUSSURGL) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

ICICI Bank Ltd and Nexus Surgical and Medicare Ltd are evenly matched on the numbers (66, 2 tied). The breakdown below shows where each one wins.

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

19.33
P/E ratio
20.78
2.78
P/B ratio
5.73
0.78%
Dividend yield
0.00%
₹75.71
EPS
₹0.91

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

16.10%
Return on equity
46.76%
7.20%
Return on capital
83.95%
0.00%
EBITDA margin
11.71%
0.00%
Net margin
8.74%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

Revenue CAGR (3Y)
71.88%
7.93%
Profit CAGR (3Y)
63.28%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹10.25L Cr
Market cap
₹11 Cr
₹0 Cr
Revenue
₹6 Cr
₹57,936 Cr
Net profit
₹1 Cr
0.00
Debt / equity
0.00
ICICI Bank Ltd
  • ["Stock is trading at 2.74 times its book value", "Company has low interest coverage ratio.", "Contingent liabilities of Rs.80,16,362 Cr.", "Earnings include an other income of Rs.1,18,852 Cr."]
Nexus Surgical and Medicare Ltd
  • + ["Company is almost debt free.", "Company has a good return on equity (ROE) track record: 3 Years ROE 53.8%"]
  • ["Promoter holding is low: 18.7%"]
ICICI Bank Ltd full analysis Nexus Surgical and Medicare Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

ICICI Bank Ltd vs NEXUSSURGL: Share Price, Valuation & Which to Buy | DocStoX